IL17A and acute respiratory distress syndrome: Increased IL-17 was noted in patients with sepsis-induced acute respiratory distress syndrome; IL-17 antibody administration might relieve acute lung injury symptoms by affecting RORγt levels and modulating the PI3K pathway.